Hinge Health Announces Pricing of Initial Public Offering SAN FRANCISCO — (BUSINESS WIRE) — Hinge Health has set the price for its initial public offering (IPO) of 13,666,000 shares of Class A common stock. Of these, 8,522,528 shares are being offered by the company, and 5,143,472 shares are being sold by certain selling stockholders. The shares are priced at $32.00 each. Additionally, the selling stockholders have given underwriters a 30-day option to purchase up to 2,049,900 additional shares of Class A common stock, at the same price but after deducting underwriting discounts and commissions. The company's shares are scheduled to start trading on the New York Stock Exchange on May 22, 2025, under the ticker symbol "HNGE." The IPO is expected to close on May 23, 2025, contingent on meeting standard closing conditions. Hinge Health plans to use the majority of the proceeds from this offering to cover tax obligations arising from the net issuance of shares of its Class A and Class B common stock, linked to the vesting and settlement of specific restricted stock units and performance-based restricted stock units. It is important to note that Hinge Health will not receive any proceeds from the sale of shares by the selling stockholders. Morgan Stanley, Barclays, and BofA Securities are the lead book-running managers for the offering. Other book-running managers include Evercore ISI, RBC Capital Markets, Truist Securities, Stifel, William Blair, Piper Sandler, Canaccord Genuity, KeyBanc Capital Markets, Needham & Company, Raymond James, and KKR Capital Markets LLC. A registration statement for these securities has been filed and declared effective by the Securities and Exchange Commission (SEC). Interested parties can obtain a copy of the prospectus, when available, from Morgan Stanley & Co. LLC, Barclays Capital Inc., or BofA Securities, Inc. Contact details for these firms are provided below: Morgan Stanley & Co. LLC: Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, Email: [email protected] Barclays Capital Inc.: c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Email: [email protected], Phone: (888) 603-5847 BofA Securities, Inc.: NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attention: Prospectus Department, Email: [email protected], Phone: (800) 294-1322 This press release does not constitute an offer to sell or a solicitation of offers to buy any securities. Any such offer or solicitation will be deemed unlawful in states or jurisdictions where securities laws require registration or qualification before the offer can be made. About Hinge Health Hinge Health is a leading provider of digital musculoskeletal (MSK) care solutions, utilizing AI and advanced software to automate a significant portion of the treatment process. The company’s platform addresses a wide range of MSK conditions, including acute injuries, chronic pain, and post-surgical rehabilitation. By easing pain, improving function, and reducing the need for surgeries, Hinge Health aims to deliver better patient outcomes and cost savings for its clients. Moreover, the platform promotes health equity by enabling users to participate in therapy sessions from anywhere. Headquartered in San Francisco, California, Hinge Health continues to innovate and expand its offerings, leveraging technology to transform the landscape of musculoskeletal care.